| Year |
Citation |
Score |
| 2020 |
Armstrong AW, Puig L, Joshi A, Skup M, Williams D, Li J, Betts KA, Augustin M. Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis. Jama Dermatology. PMID 32022825 DOI: 10.1001/Jamadermatol.2019.4029 |
0.318 |
|
| 2017 |
Suhler EB, Thorne JE, Mittal M, Betts KA, Tari S, Camez A, Bao Y, Joshi A. Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 Trials. Ophthalmology. PMID 28689898 DOI: 10.1016/J.Ophtha.2017.06.017 |
0.301 |
|
| 2017 |
Haroon M, Betts K, Mu F, Skup M, Anderson J, Joshi A. THU0753-HPR Predicting the future development of spondyloarthritis among patients with idiopathic acute anterior uveitis using real-world data Annals of the Rheumatic Diseases. 76: 1487-1487. DOI: 10.1136/Annrheumdis-2017-Eular.3028 |
0.334 |
|
| 2016 |
Deodhar A, Mittal M, Reilly P, Bao Y, Manthena S, Anderson J, Joshi A. Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay. Clinical Rheumatology. PMID 26987341 DOI: 10.1007/S10067-016-3231-Z |
0.333 |
|
| 2016 |
Betts K, Mittal M, Song J, Skup M, Joshi A. OP0115 Relative Efficacy of Adalimumab versus Secukinumab in Active Ankylosing Spondylitis: A Matching-Adjusted Indirect Comparison Annals of the Rheumatic Diseases. 75: 98.2-99. DOI: 10.1136/Annrheumdis-2016-Eular.2754 |
0.326 |
|
| 2016 |
Mease PJ, Skup M, Karki C, Etzel CJ, Malley W, Greenberg JD, Joshi A. AB0743 Characterization of Psoriatic Arthritis Patients by Skin and Joint Severity: Results from The Corrona Spondyloarthritis Registry Annals of the Rheumatic Diseases. 75: 1158-1159. DOI: 10.1136/Annrheumdis-2016-Eular.1452 |
0.343 |
|
| 2016 |
Brézin A, Chen N, Tari S, Skup M, Joshi A. THU0565 Clinical Relevance of Treatment Failure as Assessed by The 25-Item Visual Functioning Questionnaire in Patients with Intermediate-, Posterior- and Pan-Uveitis: Results from The Visual-1 Trial Annals of the Rheumatic Diseases. 75: 396.2-396. DOI: 10.1136/Annrheumdis-2016-Eular.1230 |
0.339 |
|
| 2015 |
van der Heijde D, Joshi A, Pangan AL, Chen N, Betts K, Mittal M, Bao Y. ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis. Rheumatology (Oxford, England). PMID 26316575 DOI: 10.1093/Rheumatology/Kev267 |
0.345 |
|
| 2015 |
Deodhar A, Mittal M, Joshi A, Signorovitch J, Yang M, Bao Y. SAT0237 Assessment of Salary Growth in Patients with Ankylosing Spondylitis Treated with and Without Anti-Tumor Necrosis Factor Therapy Annals of the Rheumatic Diseases. 74: 744.1-744. DOI: 10.1136/Annrheumdis-2015-Eular.3663 |
0.348 |
|
| 2015 |
Rockberg J, Mittal M, Joshi A, Bao Y, Anderson J, Linder R, Stålhammar J, Lindqvist U. OP0002 Characteristics, Referral and Treatment Patterns of Patients Diagnosed with Psoriatic Arthritis – A Retrospective Cohort Study Based in Sweden Annals of the Rheumatic Diseases. 74: 64-65. DOI: 10.1136/Annrheumdis-2015-Eular.1701 |
0.365 |
|
| 2015 |
Mease P, Mittal M, Joshi A, Chen N, Anderson J, Bao Y. SAT0578 Value of Treating Both Skin and Joint Manifestations of Psoriatic Arthritis: Post-HOC Analysis of the Adept Clinical Trial Annals of the Rheumatic Diseases. 74: 870.2-870. DOI: 10.1136/Annrheumdis-2015-Eular.1506 |
0.305 |
|
| 2015 |
Mease P, Heijde Dvd, Mittal M, Joshi A, Xu Y, Pangan A, Song I-. AB1158 Quality of Life in Patients with Active Peripheral SPA is Similarly Impaired as in Other Rheumatic Diseases and Influenced by Disease Activity But not Disease Duration Annals of the Rheumatic Diseases. 74: 1290-1290. DOI: 10.1136/Annrheumdis-2015-Eular.1471 |
0.319 |
|
| 2014 |
Wendling D, Joshi A, Reilly P, Jalundhwala YJ, Mittal M, Bao Y. Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database. Current Medical Research and Opinion. 30: 2515-21. PMID 25252590 DOI: 10.1185/03007995.2014.969368 |
0.31 |
|
| 2014 |
Ji X, Joshi A, Pérez-Campoamor SV, Hernandez RS, Botteman M, Bao Y. OP0161 A Cost-Effectiveness Model of Adalimumab (ADA) in Non-Radiographic Axial Spondyloarthritis in Spain Annals of the Rheumatic Diseases. 73: 122-123. DOI: 10.1136/Annrheumdis-2014-Eular.2403 |
0.363 |
|
| 2014 |
Maksymowych W, Boonen A, Marzo-Ortega H, Magrey M, Joshi A, Halpern M, Renaud J, Mittal M, Bao C. FRI0152 Decreased Employment, Work Productivity, and Presenteeism in Patients with Ankylosing Spondylitis is Associated with Increased Disease Activity as Measured by Basdai: Table 1. Annals of the Rheumatic Diseases. 73: 437.2-437. DOI: 10.1136/Annrheumdis-2014-Eular.2149 |
0.344 |
|
| 2013 |
Kolibaba KS, Sterchele JA, Joshi AD, Forsyth M, Alwon E, Beygi H, Kennealey GT. Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study. Therapeutic Advances in Hematology. 4: 157-71. PMID 23730494 DOI: 10.1177/2040620713478629 |
0.331 |
|
| 2013 |
Rao S, Cifaldi MA, Joshi AD, Shillington A, McGuire M, Wittig B, Rudwaleit M. SAT0567 Prevalence Estimates of Axial Spondyloarthritis among Patients in German Rheumatology Practices Annals of the Rheumatic Diseases. 72. DOI: 10.1136/Annrheumdis-2013-Eular.2291 |
0.34 |
|
| 2012 |
Joshi AD, Holdford DA, Brophy DF, Harpe SE, Mays D, Gehr TW. Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study. Anemia. 2012: 248430. PMID 22577528 DOI: 10.1155/2012/248430 |
0.583 |
|
| 2012 |
Carter JA, Joshi AD, Kaura S, Botteman MF. Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours. Pharmacoeconomics. 30: 373-86. PMID 22500986 DOI: 10.2165/11631390-000000000-00000 |
0.32 |
|
| 2011 |
Joshi AD, Patel DA, Holdford DA. Media coverage of off-label promotion: a content analysis of US newspapers. Research in Social & Administrative Pharmacy : Rsap. 7: 257-71. PMID 21272550 DOI: 10.1016/J.Sapharm.2010.06.003 |
0.618 |
|
| 2011 |
Kolibaba KS, Joshi AD, Sterchele JA, Forsyth M, Alwon E, Beygi H, Kennealey GT. Demographics, Treatment Patterns, Safety, and Real-World Effectiveness in Patients ≥70 Years of Age with Chronic Lymphocytic Leukemia Receiving Bendamustine with or without Rituximab, Blood. 118: 3914-3914. DOI: 10.1182/Blood.V118.21.3914.3914 |
0.365 |
|
| 2011 |
Patel DA, Joshi AD, Holdford DA, Saxena K. Content Analysis of Off-label Drug Use: Reporting Print Media Coverage Drug Information Journal. 45: 787-796. DOI: 10.1177/009286151104500515 |
0.626 |
|
| 2011 |
Joshi A, Holdford D, Brophy D, Harpe S. PUK17 UTILIZATION AND ECONOMIC IMPACT OF IV IRON AND ERYTHROPOIESIS STIMULATING AGENTS IN CHRONIC KIDNEY DISEASE PATIENTS: A MULTI-HOSPITAL STUDY Value in Health. 14: A77. DOI: 10.1016/J.Jval.2011.02.432 |
0.568 |
|
| Show low-probability matches. |